Anales Oftalmológicos

ANALES OFTALMOLÓGICOS Tomo VII • Vol. V • N˚3 • 2019 • Santiago - Chile BIBLIOGRAFÍA 1. Peris, K. et al. Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines. Eur. J. Cancer 118, 10–34 (2019). 2. Shi, Y., Jia, R. & Fan, X. Ocular basal cell carcinoma: A brief literature review of clinical diagnosis and treatment. Onco. Targets. Ther. 10, 2483–2489 (2017). 3. Marzuka, A. G. & Book, S. E. Basal cell carcinoma: Pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale Journal of Biology and Medicine vol. 88 167–179 (2015). 4. Cameron, M. C. et al. Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. Journal of the American Academy of Dermatology vol. 80 303–317 (2019). 5. Saleh, G. M. et al. Incidence of eyelid basal cell carcinoma in England: 2000-2010. Br. J. Ophthalmol. 101, 209–212 (2017). 6. Sun, M. T., Wu, A., Figueira, E., Huilgol, S. & Selva, D. Management of periorbital basal cell carcinoma with orbital invasion. Futur. Oncol. 11, 3003–3010 (2015). 7. Cook, B. E. & Bartley, G. B. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology 106, 746–750 (1999). 8. Margo, C. E. &Waltz, K. Basal cell carcinoma of the eyelid and periocular skin. Survey of Ophthalmology vol. 38 169–192 (1993). 9. Gallagher, R. P. et al. Sunlight Exposure, Pigmentation Factors, and Risk of Nonmelanocytic Skin Cancer: II. Squamous Cell Carcinoma. Arch. Dermatol. 131, 164–169 (1995). 10. Furdova, A. & Lukacko, P. Periocular basal cell carcinoma predictors for recurrence and infiltration of the orbit. J. Craniofac. Surg. 28, e84–e87 (2017). 11. Leibovitch, I., McNab, A., Sullivan, T., Davis, G. & Selva, D. Orbital invasion by periocular basal cell carcinoma. Ophthalmology 112, 717–723 (2005). 12. Meads, S. B. & Greenway, H. T. Basal cell carcinoma associated with orbital invasion: Clinical features and treatment options. Dermatologic Surg. 32, 442–446 (2006). 13. Malhotra, R., Huilgol, S. C., Huynh, N. T. & Selva, D. The Australian Mohs database, part II: Periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology 111, 631–636 (2004). 14. Luliano, A. et al. Risk factors for orbital exenteration in periocular basal cell carcinoma. Am. J. Ophthalmol. 153, (2012). 15. Gerring, R. C., Ott, C. T., Curry, J. M., Sargi, Z. B. &Wester, S. T. Orbital exenteration for advanced periorbital non-melanoma skin cancer: Prognostic factors and survival. Eye vol. 31 379–388 (2017). 16. Tyers, A. G. Orbital exenteration for invasive skin tumours. Eye 20, 1165–1170 (2006). 17. Satchi, K. & McNab, A. A. Orbital spread of eyelid and periocular cutaneous cancer. International Ophthalmology Clinics vol. 49 223–236 (2009). 18. Madge, S. N. et al. Globe-sparing surgery for medial canthal basal cell carcinoma with anterior orbital invasion. Ophthalmology 117, 2222–2228 (2010). 19. Finger, P. T. Radiation Therapy for Orbital Tumors: Concepts, Current Use, and Ophthalmic Radiation Side Effects. Survey of Ophthalmology vol. 54 545–568 (2009). 20. Pontoriero, A. et al. Treatment of periocular basal cell carcinoma using an advanced stereotactic device. Anticancer Res. 34, 873–5 (2014). 21. Guthrie, T. H. et al. Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: Results in 28 patients including 13 patients receiving multimodality therapy. J. Clin. Oncol. 8, 342–346 (1990). 22. Cox, K. F. & Margo, C. E. Role of vismodegib in the management of advanced periocular basal cell carcinoma. Cancer Control 23, 133–139 (2016). 23. Pfeiffer, P., Hansen, O. & Rose, C. Systemic cytotoxic therapy of basal cell carcinoma. A review of the literature. Eur. J. Cancer Clin. Oncol. 26, 73–77 (1990). 24. Gill, H. S., Moscato, E. E., Chang, A. L. S., Soon, S. & Silkiss, R. Z. Vismodegib for periocular and orbital basal cell carcinoma. JAMA Ophthalmology vol. 131 1591–1594 (2013). 25. Demirci, H., Worden, F., Nelson, C. C., Elner, V. M. & Kahana, A. Efficacy of vismodegib (erivedge) for basal cell carcinoma involving the orbit and periocular area. Ophthal. Plast. Reconstr. Surg. 31, 463–466 (2015). 26. Papastefanou, V. P. & René, C. Secondary Resistance to Vismodegib after Initial Successful Treatment of Extensive Recurrent Periocular Basal Cell Carcinoma with Orbital Invasion. in Ophthalmic Plastic and Reconstructive Surgery vol. 33 S68–S70 (Lippincott Williams and Wilkins, 2017).